» Articles » PMID: 36494744

Effects of Nasal Inflammation on the Olfactory Bulb

Overview
Publisher Biomed Central
Date 2022 Dec 10
PMID 36494744
Authors
Affiliations
Soon will be listed here.
Abstract

Sinonasal diseases, such as rhinosinusitis, affect up to 12% of individuals each year which constitutes these diseases as some of the most common medical conditions in the world. Exposure to environmental pathogens and toxicants via the nasal cavity can result in a severe inflammatory state commonly observed in these conditions. It is well understood that the epithelial and neuronal cells lining the olfactory mucosa, including olfactory sensory neurons (OSNs), are significantly damaged in these diseases. Prolonged inflammation of the nasal cavity may also lead to hyposmia or anosmia. Although various environmental agents induce inflammation in different ways via distinct cellular and molecular interactions, nasal inflammation has similar consequences on the structure and homeostatic function of the olfactory bulb (OB) which is the first relay center for olfactory information in the brain. Atrophy of the OB occurs via thinning of the superficial OB layers including the olfactory nerve layer, glomerular layer, and superficial external plexiform layer. Intrabulbar circuits of the OB which include connectivity between OB projection neurons, OSNs, and interneurons become significantly dysregulated in which synaptic pruning and dendritic retraction take place. Furthermore, glial cells and other immune cells become hyperactivated and induce a state of inflammation in the OB which results in upregulated cytokine production. Moreover, many of these features of nasal inflammation are present in the case of SARS-CoV-2 infection. This review summarizes the impact of nasal inflammation on the morphological and physiological features of the rodent OB.

Citing Articles

Preliminary Findings on the Morphometric Characteristics of the Olfactory Bulb in the Cat.

Alvites R, Caine A, Cherubini G, Varejao A, Mauricio A Animals (Basel). 2025; 14(24.

PMID: 39765495 PMC: 11672697. DOI: 10.3390/ani14243590.


Neuroimmune interactions in the olfactory epithelium: maintaining a sensory organ at an immune barrier interface.

Ullah M, Rowan N, Lane A Trends Immunol. 2024; 45(12):987-1000.

PMID: 39550314 PMC: 11624989. DOI: 10.1016/j.it.2024.10.005.


Analysis of olfactory function in patients with chronic rhinosinusitis and Staphylococcus aureus enterotoxin positivity.

Kim M, Chae H, Kwon D, Jeon E, Lee Y, Lee E Sci Rep. 2024; 14(1):26138.

PMID: 39478131 PMC: 11525943. DOI: 10.1038/s41598-024-77459-7.


Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity.

Niemeyer C, Merle L, Bubak A, Baxter B, Gentile Polese A, Colon-Reyes K J Virol. 2024; 98(11):e0096824.

PMID: 39475273 PMC: 11575344. DOI: 10.1128/jvi.00968-24.


Inflammation and olfactory loss are associated with at least 139 medical conditions.

Leon M, Troscianko E, Woo C Front Mol Neurosci. 2024; 17:1455418.

PMID: 39464255 PMC: 11502474. DOI: 10.3389/fnmol.2024.1455418.


References
1.
Nagayama S, Enerva A, Fletcher M, Masurkar A, Igarashi K, Mori K . Differential axonal projection of mitral and tufted cells in the mouse main olfactory system. Front Neural Circuits. 2010; 4. PMC: 2952457. DOI: 10.3389/fncir.2010.00120. View

2.
Mori K, Nagao H, Yoshihara Y . The olfactory bulb: coding and processing of odor molecule information. Science. 1999; 286(5440):711-5. DOI: 10.1126/science.286.5440.711. View

3.
Kishimoto-Urata M, Urata S, Kagoya R, Imamura F, Nagayama S, Reyna R . Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit. Sci Rep. 2022; 12(1):5728. PMC: 8987081. DOI: 10.1038/s41598-022-09731-7. View

4.
Rustenhoven J, Drieu A, Mamuladze T, de Lima K, Dykstra T, Wall M . Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021; 184(4):1000-1016.e27. PMC: 8487654. DOI: 10.1016/j.cell.2020.12.040. View

5.
Kaufer C, Schreiber C, Hartke A, Denden I, Stanelle-Bertram S, Beck S . Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022; 79:103999. PMC: 9013202. DOI: 10.1016/j.ebiom.2022.103999. View